Panagopoulos Ioannis, Mertens Fredrik, Dêbiec-Rychter Maria, Isaksson Margareth, Limon Janusz, Kardas Iwona, Domanski Henryk A, Sciot Raf, Perek Danuta, Crnalic Sead, Larsson Olle, Mandahl Nils
Department of Clinical Genetics, Lund University Hospital, SE-221 85 Lund, Sweden.
Int J Cancer. 2002 Jun 1;99(4):560-7. doi: 10.1002/ijc.10404.
Clear cell sarcoma (CCS) is a rare malignant soft tissue tumor particularly associated with tendons and aponeuroses. The cytogenetic hallmark is the translocation t(12;22)(q13;q12) resulting in a chimeric EWS/ATF1 gene in which the 3'-terminal part of EWS at 22q is replaced by the 3'-terminal part of ATF1 at 12q. To date, only 13 cases of CCS have been analyzed for fusion genes at the transcription level, and there is no information about the breakpoints at the genomic level. In the present study, we describe the molecular genetic characteristics of CCS from 10 patients. Karyotypes were obtained from 10 cases, 7 of which showed the characteristic t(12;22). As an initial step in the characterization of the EWS/ATF1 and ATF1/EWS chimeras, we constructed an exon/intron map of the ATF1 gene. The entire ATF1 gene spanned >40 kb and was composed of 7 exons. Intron 3, in which most of the genomic breakpoints occurred, was to a large extent (83%) composed of repetitive elements. RT-PCR amplified EWS/ATF1 cDNA fragments in all patients and ATF1/EWS cDNA fragments in 6 of 10 patients. Four types of EWS/ATF1 chimeric transcript, designated types 1-4, were identified. The most frequent chimeric transcript (type 1) was an in-frame fusion of exon 8 of EWS with exon 4 of ATF1. This was the only chimeric transcript in 5 patients but found together with other variants in 3 tumors. The type 2 transcript of EWS/ATF1, an in-frame fusion of exon 7 of EWS with exon 5 of ATF1, was detected in 4 patients, as the only transcript in 1 case and together with other variants in 3 cases. An in-frame fusion of exon 10 of EWS with exon 5 of ATF1 (type 3) was found in 1 patient as the only transcript, and an out-of-frame fusion of EWS exon 7 with ATF1 exon 7 (type 4) was detected in 1 patient together with type 1 and type 2 transcripts. Sequencing of the amplified ATF1/EWS cDNA fragments showed in 5 patients that ATF1 exon 3 was fused with EWS exon 10, resulting in an out-of-frame chimeric transcript. In 1 case, nt 428 of ATF1 (exon 4) was fused with EWS exon 8; at the junction, there was an insertion of 4 nucleotides, also resulting in an out-of-frame transcript. Genomic extra long PCR and sequence analysis mapped the genomic breakpoints to introns 7, 8 and 9 of EWS and intron 3 and exon 4 of ATF1. While a simple end-to-end fusion was observed in 2 cases, additional nucleotides were found at the junctions in 2 other cases. In addition, topoisomerase I consensus sequences were found close to the junctions, suggesting that this enzyme may participate in the genesis of the EWS/ATF1 fusion.
透明细胞肉瘤(CCS)是一种罕见的恶性软组织肿瘤,尤其与肌腱和腱膜相关。细胞遗传学特征是t(12;22)(q13;q12)易位,导致嵌合的EWS/ATF1基因,其中位于22q的EWS的3'-末端部分被位于12q的ATF1的3'-末端部分取代。迄今为止,仅对13例CCS病例进行了转录水平融合基因分析,尚无基因组水平断点的相关信息。在本研究中,我们描述了10例患者的CCS分子遗传学特征。从10例病例中获得了核型,其中7例显示出特征性的t(12;22)。作为EWS/ATF1和ATF1/EWS嵌合体特征描述的第一步,我们构建了ATF1基因的外显子/内含子图谱。整个ATF1基因跨度超过40kb,由7个外显子组成。内含子3是大多数基因组断点所在之处,在很大程度上(83%)由重复元件组成。逆转录-聚合酶链反应(RT-PCR)在所有患者中扩增出EWS/ATF1 cDNA片段,在10例患者中的6例中扩增出ATF1/EWS cDNA片段。鉴定出4种类型的EWS/ATF1嵌合转录本,命名为1-4型。最常见的嵌合转录本(1型)是EWS的外显子8与ATF1的外显子4的读码框内融合。这是5例患者中的唯一嵌合转录本,但在3个肿瘤中与其他变体同时存在。EWS/ATF1的2型转录本是EWS的外显子7与ATF1的外显子5的读码框内融合,在4例患者中检测到,1例为唯一转录本,3例与其他变体同时存在。在1例患者中发现EWS的外显子10与ATF1的外显子5的读码框内融合(3型)为唯一转录本,在1例患者中检测到EWS外显子7与ATF1外显子7的读码框外融合(4型),同时还有1型和2型转录本。扩增的ATF1/EWS cDNA片段测序显示,5例患者中ATF1外显子3与EWS外显子10融合,产生读码框外嵌合转录本。在1例中,ATF1(外显子4)的第428位核苷酸与EWS外显子8融合;在连接处有4个核苷酸插入,也产生读码框外转录本。基因组超长PCR和序列分析将基因组断点定位到EWS的内含子7、8和9以及ATF1的内含子3和外显子4。在2例中观察到简单的端对端融合,在另外2例的连接处发现了额外的核苷酸。此外,在连接处附近发现了拓扑异构酶I共有序列,提示该酶可能参与EWS/ATF1融合的发生。